Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era

被引:0
|
作者
Sweiss, Karen [1 ,2 ]
Oh, Annie L. [3 ]
Calip, Gregory S. [4 ]
Rondelli, Damiano [2 ,3 ]
Patel, Pritesh R. [2 ,3 ]
机构
[1] Univ Illinois, Dept Pharm Practice, Chicago, IL 60607 USA
[2] Univ Illinois, Canc Ctr, Chicago, IL 60607 USA
[3] Univ Illinois, Div Hematol Oncol, Chicago, IL 60607 USA
[4] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL 60607 USA
关键词
D O I
10.1182/blood.V128.22.4631.4631
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4631
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Dose intensive induction chemotherapy does not decrease tumor contamination of autograft or improve survival for multiple myeloma patients undergoing autologous stem cell transplant
    Sayani, FA
    Bahlis, NJ
    Faris, P
    Savoie, ML
    Chaudhry, A
    Jeje, O
    Brown, CB
    Russell, JA
    Stewart, DA
    BLOOD, 2005, 106 (11) : 823A - 823A
  • [22] Response Evaluation Using PET/CT in Multiple Myeloma Patients Undergoing Autologous Transplant
    Ellis-Caleo, Tim
    Sidana, Surbhi
    Liedtke, Michaela
    Iberri, David
    BLOOD, 2020, 136
  • [23] Risk of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant
    Awada, Hussein
    Ali, Adel Hajj
    Faiman, Beth M.
    Winter, Allison
    Mazzoni, Sandra
    Samaras, Christy J.
    Sauter, Craig S.
    van Heeckeren, Willem J.
    Dean, Robert M.
    Pohlman, Brad
    Hill, Brian T.
    Valent, Jason
    Sobecks, Ronald M.
    Williams, Louis S.
    Jagadeesh, Deepa
    Hamilton, Betty K.
    Kalaycio, Matt
    Anwer, Faiz
    Khouri, Jack
    BLOOD, 2022, 140 : 10596 - 10597
  • [24] Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group
    S Y Ong
    S de Mel
    Y X Chen
    M G Ooi
    S Surendran
    A Lin
    L P Koh
    Y C Linn
    A Y L Ho
    W Y K Hwang
    C Phipps
    S M Y Loh
    Y T Goh
    D Tan
    W J Chng
    S K Gopalakrishnan
    Bone Marrow Transplantation, 2016, 51 : 933 - 937
  • [25] Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group
    Ong, S. Y.
    de Mel, S.
    Chen, Y. X.
    Ooi, M. G.
    Surendran, S.
    Lin, A.
    Koh, L. P.
    Linn, Y. C.
    Ho, A. Y. L.
    Hwang, W. Y. K.
    Phipps, C.
    Loh, S. M. Y.
    Goh, Y. T.
    Tan, D.
    Chng, W. J.
    Gopalakrishnan, S. K.
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 933 - 937
  • [26] Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups
    Afram, Gabriel
    Susek, Katharina Helene
    Uttervall, Katarina
    Wersall, Johanna Dehlsen
    Wagner, Arnika Kathleen
    Luong, Vincent
    Lund, Johan
    Gahrton, Gosta
    Alici, Evren
    Nahi, Hareth
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 546 - 554
  • [27] Low Pre-Transplant Vitamin D Levels Predict an Inferior Survival in Patients with Multiple Myeloma Undergoing an Autologous Stem Cell Transplant
    Rakhee, Vaidya
    Ahlers, Shane
    Rodriguez, Cesar
    Lamar, Zanetta S.
    Hurd, David D.
    BLOOD, 2016, 128 (22)
  • [28] Conditional Survival in Patients with Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplantation
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Anwer, Faiz
    Dean, Robert M.
    Hamilton, Betty K.
    Jagadeesh, Deepa
    Kalaycio, Matt E.
    Sobecks, Ronald M.
    Valent, Jason
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [29] Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
    Desai, Sanjal H.
    Spinner, Michael A.
    Evens, Andrew M.
    Sykorova, Alice
    Bachanova, Veronika
    Goyal, Gaurav
    Kahl, Brad
    Dorritie, Kathleen
    Azzi, Jacues
    Kenkre, Vaishalee P.
    Chang, Cheryl
    Michalka, Jozef
    Ansell, Stephen M.
    Fusco, Brendon
    Sumransub, Nuttavut
    Hatic, Haris
    Saba, Raya
    Ibrahim, Uroosa
    Harris, Elyse I.
    Shah, Harsh
    Wagner-Johnston, Nina
    Arai, Sally
    Nowakowski, Grzegorz S.
    Mocikova, Heidi
    Jagadeesh, Deepa
    Blum, Kristie A.
    Diefenbach, Catherine
    Iyengar, Siddharth
    Rappazzo, K. C.
    Baidoun, Firas
    Choi, Yun
    Prochazka, Vit
    Advani, Ranjana H.
    Micallef, Ivana
    BLOOD ADVANCES, 2023, 7 (23) : 7295 - 7303
  • [30] Impact of early relapse on survival of patients with multiple myeloma after autologous cell transplant
    Seehaus, Cristian
    Schutz, Natalia
    Cataldo, Federico
    Brulc, Erika
    Arbelbide, Jorge
    Fantl, Dorotea
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S188